Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trametinib for Complex Vascular Malformations in Children
ChiCTR2400083536Phase 3Completed
- Sponsor
- Beijing Children's Hospital
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of trametinib in vascular malformation and arteriovenous malformation (AVM), sponsored by Beijing Children's Hospital. Primary endpoints: Skin color, Skin temperature and 1 more. Started Nov 2023; status: completed.
02
Drugs
trametinib
03
Conditions
vascular malformationarteriovenous malformation (AVM)
Beyond the preview
Go deeper on ChiCTR2400083536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083536.